Back to search
FDAFDA · Food and drugs·Recall number D-66373-001

Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01.

Published October 16, 2013 · Recall initiated: September 25, 2013

Summary

FDA records drug Class III recall D-66373-001, published October 16, 2013 and initiated September 25, 2013. Recalling firm: Sandoz Incorporated; Status: Terminated; Reported quantity: 25,830 bottles; Lot: Lot #: BU3417, Exp 06/2014. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz Incorporated
Distributor
Nationwide
Lot
Lot #: BU3417, Exp 06/2014
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01. recalled?

Yes. FDA published recall D-66373-001 on October 16, 2013. Reported hazard: Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter